Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort
Müge Akinci, Froogh Aziz, Priya Palta, Diana Guzman, Lina Cheung, Jeanne A. Teresi, Adam M. Brickman, Patrick J. Lao et al.. JAMA Network Open, 2026-01-27
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
A total of 503 participants (mean [SD] age, 64.6 [2.8] years; 321 [63.8%] women; 305 [60.6%] Hispanic, 120 [23.9%] non-Hispanic Black, and 78 [15.5%] non-Hispanic White) with Aβ PET, MRI (n = 501), and tau PET (n = 355) data were studied. Compared with men, women had greater amyloid burden (B = 0.05; 95% CI, 0.02-0.07; P < .001), Braak stages III and IV (B = 0.05; 95% CI, 0.02-0.08; P = .003) and Braak stages V and VI (B = 0.09; 95% CI, 0.06-0.12; P < .001) tau burden, and AD signature thickness (B = 0.04; 95% CI, 0.02-0.05; P < .001). A significant sex × APOE ε4 interaction was observed, with women showing greater Braak stages I and II (B = 0.15; 95% CI, 0.04-0.25; P = .006) and Braak stages III and IV (B = 0.08; 95% CI, 0.02-0.14; P = .01) tau burden than men among APOE ε4 carriers. All findings remained statistically significant after FDR correction. No significant sex × age or sex × race and ethnicity interactions were observed on any outcome. Conclusions and Relevance: This cross-sectional study of community-based adults found greater AD pathology yet better preserved structural brain integrity in women compared with men. Sex differences in tau burden across early to middle Braak stages were more pronounced among APOE ε4 carriers compared with noncarriers. These findings were not modified by age or race and ethnicity. Overall, the results underscore sex-specific distinctions in AD pathology burden and brain structure at the cross-sectional level.
What this study adds
Evidence grade: Moderate
This is a cross-sectional study of 501 participants. In this cross-sectional study, women had greater amyloid and tau burden than men, and sex differences in tau burden at early to middle Braak stages were more pronounced among APOE ε4 carriers. Reported effect size: 63.8%; 60.6%; 23.9%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Akinci, M., Aziz, F., Palta, P., Guzman, D., Cheung, L., Teresi, J. A., et al. (2026). Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.54524
Vancouver
Akinci M, Aziz F, Palta P, Guzman D, Cheung L, Teresi JA, et al. Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort. JAMA Network Open. 2026. doi:10.1001/jamanetworkopen.2025.54524. PMID: 41591778.
BibTeX
@article{akinci2026-41591778,
author = {Akinci, Müge and Aziz, Froogh and Palta, Priya and Guzman, Diana and Cheung, Lina and Teresi, Jeanne A. and Brickman, Adam M. and Lao, Patrick J. and others},
title = {{Sex Differences in Alzheimer Disease Imaging Biomarkers in a Diverse, Community-Based Cohort}},
journal = {JAMA Network Open},
year = {2026},
doi = {10.1001/jamanetworkopen.2025.54524},
pmid = {41591778},
url = {https://doi.org/10.1001/jamanetworkopen.2025.54524}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- A total of 503 participants (mean [SD] age, 64.6 [2.8] years; 321 [63.8%] women; 305 [60.6%] Hispanic, 120 [23.9%] non-Hispanic Black, and 78 [15.5%] non-Hispanic White) with Aβ PET, MRI (n = 501), and tau PET (n = 355) data were studied.
- Compared with men, women had greater amyloid burden (B = 0.05; 95% CI, 0.02-0.07; P < .001), Braak stages III and IV (B = 0.05; 95% CI, 0.02-0.08; P = .003) and Braak stages V and VI (B = 0.09; 95% CI, 0.06-0.12; P < .001) tau burden, and AD signature thickness (B = 0.04; 95% CI, 0.02-0.05; P < .001).
- A significant sex × APOE ε4 interaction was observed, with women showing greater Braak stages I and II (B = 0.15; 95% CI, 0.04-0.25; P = .006) and Braak stages III and IV (B = 0.08; 95% CI, 0.02-0.14; P = .01) tau burden than men among APOE ε4 carriers.
- All findings remained statistically significant after FDR correction.
- No significant sex × age or sex × race and ethnicity interactions were observed on any outcome.
Why it matters
In this cross-sectional study, women had greater amyloid and tau burden than men, and sex differences in tau burden at early to middle Braak stages were more pronounced among APOE ε4 carriers. The study describes imaging differences only and reports no treatment, cure, or prevention findings.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Study designcross-sectional
- Participants501
- Effect size63.8%; 60.6%; 23.9%
- Evidence strengthModerate
How this study scored 55/100
Published in a leading specialty journal, and it is a snapshot of people at one point in time. Scored zero for randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (JAMA Network Open) |
| Journal's citation record | 2 / 4 | JAMA Network Open: journal h-index 235 (OpenAlex, 2026-10-29) |
| Study design | 4 / 12 | A snapshot of people at one point in time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 2 / 4 | 501 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 4 / 6 | Cited 19.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author José A. Luchsinger: h-index 2 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Columbia University: institution h-index 1,824 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41591778) |
| Free to read | 2 / 2 | Free to read |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1001/jamanetworkopen.2025.54524
- PubMed: 41591778
- Original source →
- Free full text: JAMA Network Open →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 30.
Related studies in Genetics from nearby years
Also tagged “machine”
834 studies in the library carry the topic tag “machine”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 834 tagged studies.